Help to reduce sitting time in prostate cancer survivors
Part of Cancer, Kidney & urinary clinical trials.
This study tests an intervention to help prostate cancer survivors sit less and move more. It may help improve daily activity and reduce long periods of inactivity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older
- Have prostate cancer that is localized or without symptoms from spread (asymptomatic metastatic)
- Not currently doing radiation or chemotherapy
- Usually get less than 150 minutes per week of moderate or vigorous exercise and sit more than 8 hours per day
- Live in Canada and can speak English well enough to take part
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether breaking up long periods of sitting can improve whole-body cardiovascular (heart and blood vessel) health. You may qualify if you’re currently quite sedentary but otherwise able to walk and climb stairs.
This study tests if a smartphone app can help people who are not very active start and stick with an exercise program. It’s designed for adults ages 40–70 who want to become more independent in their exercise routine.
This study tests a program to help older adults with heart disease and frailty reduce the amount of time they sit or lie down during the day. The goal is to see if reducing sitting time can improve strength, energy, and overall health.
This study tests a program to help cancer survivors sit less each day. You will learn simple habits to break up long periods of sitting, which may improve your health and well-being.
This study tests a behavior change program to help cancer survivors become more physically active. You will receive support through video calls and a smartphone app to build a healthier routine after cancer treatment.
This Phase 2 study tests whether a structured exercise and lifestyle program, tracked with a Fitbit, can reduce cardiovascular (heart) risk in men with prostate cancer on hormone therapy. It also checks whether this is safe and feasible while monitoring symptoms and fitness changes.
Hear when a new Sedentary Behavior trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.